European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18 F‐fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus-Reference-Cited by-同舟云学术

European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18 F‐fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus

Published:2018-07-20 Issue:10 Volume:25 Page:1201-1217
ISSN:1351-5101
Container-title:European Journal of Neurology
language:en
Short-container-title:Eur J Neurol

Author:

Nobili F.¹^ORCID,Arbizu J.²,Bouwman F.³^ORCID,Drzezga A.⁴,Agosta F.⁵,Nestor P.⁶,Walker Z.⁷,Boccardi M.⁸,Festari Cristina,Altomare Daniele,Gandolfo Federica,Orini Stefania,

Affiliation:

1. Department of Neuroscience (DINOGMI) University of Genoa and Polyclinic San Martino Hospital Genoa Italy

2. Department of Nuclear Medicine Clinica Universidad de Navarra University of Navarra Pamplona Spain

3. Department of Neurology and Alzheimer Center Amsterdam Neuroscience VU University Medical Center Amsterdam The Netherlands

4. Department of Nuclear Medicine University Hospital of Cologne University of Cologne and German Center for Neurodegenerative Diseases (DZNE) Cologne Germany

5. Neuroimaging Research Unit Institute of Experimental Neurology Division of Neuroscience San Raffaele Scientific Institute Vita‐Salute San Raffaele University Milan Italy

6. German Center for Neurodegenerative Diseases (DZNE) Magdeburg Germany

7. Division of Psychiatry Essex Partnership University NHS Foundation Trust University College London London UK

8. Department of Psychiatry Laboratoire du Neuroimagerie du Vieillissement (LANVIE) University of Geneva Geneva Switzerland

Funder

European Association of Nuclear Medicine

European Academy of Neurology

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ene.13728

Reference119 articles.

1. Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers

2. Decision Memo for Positron Emission Tomography (FDG) and Other Neuroimaging Devices for Suspected Dementia (CAG‐00088R).2004;https://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=104.

3. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria

4. The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

5. Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

Cited by 149 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A multi-scale feature selection module based architecture for the diagnosis of Alzheimer’s disease on [18F]FDG PET;International Journal of Medical Informatics;2024-11

2. Brain 18FDG-PET pattern in cognitively impaired elderly patients with bipolar disorder;2024-08-29

3. Neuroimaging biomarkers in the biological definition of Parkinson’s disease and dementia with Lewy bodies – EANM position on current state, unmet needs and future perspectives;European Journal of Nuclear Medicine and Molecular Imaging;2024-06-22

4. Evaluation of the Therapeutical Effect of Matricaria Chamomilla Extract vs. Galantamine on Animal Model Memory and Behavior Using 18F-FDG PET/MRI;Current Issues in Molecular Biology;2024-05-09

5. Markers of neurodegenerative dementias: the contribution of neuroimaging and neurophysiological methods;Neurologie pro praxi;2024-04-16